Qube Research & Technologies LTD Edwards Lifesciences Corp Transaction History

Qube Research & Technologies LTD

$72.9 Billion
Q4 2024

A detailed history of Qube Research & Technologies LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,000 shares of EW stock, worth $72,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000

Previous 626,768 99.84%

Holding current value

$72,480

Previous $41.4 Million 99.82%

% of portfolio

0.0%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $37.4 Million - $58.8 Million	626,768 New	626,768 $41.4 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $15.3 Million - $20.1 Million	-210,665 Reduced 97.78%	4,793 $458,000
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $11.3 Million - $14.2 Million	-182,439 Reduced 45.85%	215,458 $16.4 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $26 Million - $35 Million	374,577 Added 1606.25%	397,897 $27.6 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $12.9 Million - $14.9 Million	-157,912 Reduced 87.13%	23,320 $2.2 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $8.77 Million - $9.98 Million	-118,044 Reduced 39.44%	181,232 $15 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $1.69 Million - $2.17 Million	-24,782 Reduced 7.65%	299,276 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $26.7 Million - $34.8 Million	324,058 New	324,058 $26.8 Million
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $9.84 Million - $12.1 Million	-92,525 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $8.05 Million - $9.61 Million	78,253 Added 548.3%	92,525 $10.5 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $1.2 Million - $1.5 Million	14,272 New	14,272 $1.48 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $5.37 Million - $6.19 Million	-68,273 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $3.1 Million - $3.94 Million	43,196 Added 172.25%	68,273 $6.23 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $4.05 Million - $5.27 Million	-60,268 Reduced 70.62%	25,077 $2 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.86 Million - $2.49 Million	32,370 Added 61.1%	85,345 $5.9 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $2.78 Million - $4.29 Million	52,975 New	52,975 $9.99 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $721,735 - $884,492	-11,726 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$55.74 - $64.41 $162,928 - $188,270	2,923 Added 33.2%	11,726 $2.17 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $330,393 - $441,880	6,899 Added 362.34%	8,803 $1.68 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $179,421 - $220,130	-3,866 Reduced 67.0%	1,904 $292,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $263,689 - $334,833	5,770 New	5,770 $1.01 Million

Others Institutions Holding EW

# of Institutions

1,384

Shares Held

454M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Edwards Lifesciences Corp Transaction History